1 |
Eu-approved roactemra |
- |
- |
- |
- |
046 1件: 46 💬 |
2 |
Roactemra |
- |
- |
- |
- |
040 9件: 40, 41, 46, 51, 86, 107, 266, 271, 331 💬 |
3 |
Roactemra (r) |
- |
- |
- |
- |
046 1件: 46 💬 |
4 |
Roactemra 162 mg |
- |
- |
- |
- |
046 2件: 46, 51 💬 |
5 |
Roactemra 162 mg solution for injection in pre-filled syringe |
- |
- |
- |
- |
041 1件: 41 💬 |
6 |
Roactemra 162 mg solution injectable en seringue préremplie |
- |
- |
- |
- |
046 1件: 46 💬 |
7 |
Roactemra 20 mg/ml concentrado para solución para perfusión |
- |
- |
- |
- |
046 1件: 46 💬 |
8 |
Roactemra 20 mg/ml concentrate for solution for infusion |
- |
- |
- |
- |
046 1件: 46 💬 |
9 |
Roactemra 20 mg/ml concentrate for solution for infusion. |
- |
- |
- |
- |
046 1件: 46 💬 |
10 |
Roactemra 20 mg/ml, concentrado para solución para perfusión |
- |
- |
- |
- |
046 2件: 46, 271 💬 |
11 |
Roactemra 20mg/ml |
- |
- |
- |
- |
040 1件: 40 💬 |
12 |
Roactemra(r) |
- |
- |
- |
- |
046 1件: 46 💬 |
13 |
Roactemra® |
- |
- |
- |
- |
046 2件: 46, 271 💬 |
14 |
Roactemra® 20mg/ml konzentrat |
- |
- |
- |
- |
266 1件: 266 💬 |
15 |
Roactemra®ev product code: prd82321 |
- |
- |
- |
- |
046 1件: 46 💬 |
16 |
Tocilizumab (actemra or roactemra) |
Tocilizumab |
1件: D02596 D02596 💬 |
IL6R 1件: IL6R 💬 |
Coronavirus disease - COVID-19 12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
046 1件: 46 💬 |
17 |
Tocilizumab [roactemra/actemra] |
Tocilizumab |
1件: D02596 D02596 💬 |
IL6R 1件: IL6R 💬 |
Coronavirus disease - COVID-19 12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
046 4件: 46, 51, 107, 331 💬 |
18 |
Tocilizumab [roactemra] |
Tocilizumab |
1件: D02596 D02596 💬 |
IL6R 1件: IL6R 💬 |
Coronavirus disease - COVID-19 12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
046 1件: 46 💬 |